PTSD Linked to Urinary Incontinence in Female Veterans
Posttraumatic stress disorder (PTSD) is independently associated with urgency/mixed urinary incontinence (UI) symptoms in female veterans.
Posttraumatic stress disorder (PTSD) is independently associated with urgency/mixed urinary incontinence (UI) symptoms in female veterans.
Men receiving testosterone supplementation who also receive dutasteride, which blocks the conversion of testosterone to its potent metabolite 5α-dihydrotestosterone (DHT), do not experience a significant difference in changes in muscle-related measures or sexual function compared to men receiving testosterone without dutasteride.
Early-onset of male pattern baldness (androgenetic alopecia [AGA]) may be a marker of male urinary symptoms associated with an enlarged prostate.
A significant correlation between coronary artery disease (CAD) and prostate cancer (PCa) has been found among men participating in a prostate drug trial.
This patient information fact sheet provides information on the definition, symptoms, treatments and self-help measures for benign prostatic hyperplasia (BPH).
Cialis (tadalafil; Lilly) tablets for once daily use have been approved for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (BPH).
Greenstone announced a recall of medicines labeled with the Lot # FI0510058-A because they may be mislabeled.
The FDA has approved GlaxoSmithKline’s Jalyn, a fixed dose combination of dutasteride and tamsulosin, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
Amgen announced results from its Phase 3, head-to-head trial that compared denosumab to Zometa (zoledronic acid, from Novartis) in 1,901 patients with bone metastases from hormone-refractory prostate cancer.